Helen of Troy Ltd’s recent filing unveils that its Chief Executive Officer Grass Brian acquired Company’s shares for reported $0.21 million on Jul 15 ’25. In the deal valued at $21.47 per share,10,000 shares were bought. As a result of this transaction, Grass Brian now holds 135,932 shares worth roughly $2.73 million.
Then, SCHEUERMAN TRACY bought 10,000 shares, generating $201,300 in total proceeds. Upon buying the shares at $20.13, the Chief Financial Officer now owns 33,041 shares.
Canaccord Genuity downgraded its Helen of Troy Ltd [HELE] rating to a Hold from a a Buy in a research note published recently. A number of analysts have revised their coverage, including DA Davidson’s analysts, who decreased its forecast for the stock in early July from “a Buy” to “a Neutral”. UBS began covering HELE with “Neutral” recommendation on April 17, 2023. DA Davidson revised its rating on December 22, 2022. It rated HELE as “a Buy” which previously was an “a Neutral”.
Price Performance Review of HELE
On Tuesday, Helen of Troy Ltd [NASDAQ:HELE] saw its stock fall -7.65% to $20.05. Over the last five days, the stock has lost -35.92%. Helen of Troy Ltd shares have fallen nearly -68.90% since the year began. Nevertheless, the stocks have fallen -66.49% over the past one year. While a 52-week high of $77.95 was reached on 01/27/25, a 52-week low of $21.07 was recorded on 07/15/25.
Levels Of Support And Resistance For HELE Stock
The 24-hour chart illustrates a support level at 19.44, which if violated will result in even more drops to 18.82. On the upside, there is a resistance level at 21.25. A further resistance level may holdings at 22.44.
How much short interest is there in Helen of Troy Ltd?
A steep rise in short interest was recorded in Helen of Troy Ltd stocks on 2025-06-13, growing by 0.2 million shares to a total of 2.83 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 2.63 million shares. There was a rise of 7.08%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on November 17, 2022 when Canaccord Genuity began covering the stock and recommended ‘”a Buy”‘ rating along with a $120 price target.
